Lebwohl, Mark G, Jeffrey L Sugarman, Linda Stein Gold, Tina Lin, and Gina Martin. “Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Severe Plaque Psoriasis: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S29. Accessed March 28, 2024. https://www.jofskin.org/index.php/skin/article/view/756.